Mark Gerhard, technology pioneer and serial entrepreneur, joins Pulsiv as Chairman
The former CEO of computer games developer Jagex has a long history of growing and exiting businesses in the games, artificial intelligence and cyber-security sectors.
Read moreFieldwork Robotics raises £1.5 million and appoints new CEO
Fieldwork Robotics is aiming to have 100 raspberry-harvesting robots in operation by 2025 following a £1.5 million investment from Elbow Beach Capital, a specialist in sustainable energy, decarbonsisation and social impact businesses.
Read moreEmporia4KT reaches concludes successfully
A major pan-European project to boost technology transfer in the Blue Economy across the Atlantic seaboard has come to end. Learn more about how Frontier IP helped.
Read moreTopps Tiles launches Alusid-made wall tiles
Topps Tiles, the UK’s no.1 tile specialist, has launched Principle, a range of mass-produced wall tiles made from recycled materials made by portfolio company Alusid.
Read moreNigel Grierson and Dr David Holbrook join the Frontier IP board of directors
Dame Julia King, Baroness Brown of Cambridge becomes Senior Independent Director as Frontier IP broadens experience on board with two new non-executive directors.
Read moreHalf year results: portfolio makes significant commercial and technical progress
Frontier IP and our portfolio companies attracted major industry interest during the first half of the year, despite difficult markets impacting the financial results.
Read moreAlusid extends product range in collaboration with world leader Imerys
Alusid has successfully collaborated with world-leading specialty minerals group Imerys to create floor tiles after becoming one of two winners in a global competition.
Read moreCelerum appoints Chief Executive Officer
Celerum has appointed David Gladding, who has more than 30 years’ experience at senior levels in software and IT services companies as CEO.
Read moreDARPA-funded TVG project develops transmissible Lassa fever vaccine candidate
Trial of transmissible Lassa fever candidate vaccine for use in rats to reduce its the threat to humans as part of project funded by the US Defense Advanced Research Projects Agency.
Read moreTVG successfully completes Anglo-Chinese pig vaccine project
The Company has developed a vaccine candidate to tackle Streptococcus suis, a disease endemic in the global pig population. It can also jump to humans, causing meningitis and septicaemia. The project was backed by the UK Department of Health and Social Care, Innovate UK and the Chinese Ministry of Science and Technology.
Read more